Red+blue Strategies
Red+blue Strategies is a lobbying firm that has earned $23.8M in lobbying income across 382 filings, representing 25 clients over 8 years (2018–2025). The firm employs 5 lobbyists across 5 policy issue areas.
🤖
AI Overview
Red+blue Strategies has earned $23.8M in lobbying income across 382 filings, representing 25 clients. It is a significant player in the federal lobbying industry. across 5 policy areas. Active from 2018 to 2025.
$23.8M
Total Income
25
Clients
5
Lobbyists
382
Filings
Income by Year
| Year | Lobbying Income |
|---|---|
| 2018 | $2.1M |
| 2019 | $2.8M |
| 2020 | $3.0M |
| 2021 | $3.2M |
| 2022 | $3.1M |
| 2023 | $3.3M |
| 2024 | $2.2M |
| 2025 | $3.9M |
Clients (25)
Coherus BiosciencesWills Eye HospitalThe Guardian Life Insurance Company of AmericaExpress Scripts INC.Community CatalystCambia Health Solutions (Formerly Known as the Regence Group)Davita INC.Blue Cross Blue Shield of MassachusettsChildren's Hospital Association F/K/A Nat'l Association of Children's HospitalsPharmaceutical Care Management Association (Pcma)Pew Charitable TrustsCarefirst Bluecross BlueshieldAmerican Society From Radiation Oncology (Astro)Boston Medical CenterQuest Diagnostics IncorporatedBaycare Health SystemCigna CorporationGE HealthcareGreater New York Hospital AssociationAmerican Hospital AssociationGenedx, LLCArcher AviationMount Sinai Hospitals Group, INCHpa Management Group INC.Karoo Health
Lobbyists (5)
Issue Areas (5)
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.